Liangqing M. Yao

1Department Of Gynecology, 419 Fangxie Road
Shanghai, 200011, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications

Neoadjuvant chemotherapy-induced immune remodeling in ovarian cancer: implications for TIL dynamics and combination immunotherapy.

Neoadjuvant chemotherapy-induced immune remodeling in ovarian cancer: implications for TIL dynamics and combination immunotherapy.

Journal: Frontiers in immunology
Published: November 30, 2025

MEOX1 Coordinates Autocrine-Paracrine Programs via SPHK1/S1P to Promote Lymph Node Metastasis in Ovarian Cancer.

MEOX1 Coordinates Autocrine-Paracrine Programs via SPHK1/S1P to Promote Lymph Node Metastasis in Ovarian Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 26, 2025

Patient-reported outcomes after long-term period of niraparib maintenance in platinum-sensitive recurrent ovarian cancer: a prospective, multicenter cohort study.

Patient-reported outcomes after long-term period of niraparib maintenance in platinum-sensitive recurrent ovarian cancer: a prospective, multicenter cohort study.

Journal: Journal of ovarian research
Published: May 21, 2025

Proteome-Wide Mendelian Randomization Analysis to Identify Potential Plasma Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer Subtypes.

Proteome-Wide Mendelian Randomization Analysis to Identify Potential Plasma Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer Subtypes.

Journal: International journal of women's health
Published: September 10, 2024

Advancing Ovarian Cancer Therapeutics: The Role of Targeted Drug Delivery Systems.

Advancing Ovarian Cancer Therapeutics: The Role of Targeted Drug Delivery Systems.

Journal: International journal of nanomedicine
Published: May 15, 2024

A Reinterpretation of Paracolpium in Radical Hysterectomy: New Insights into Its Surgical Implication.

A Reinterpretation of Paracolpium in Radical Hysterectomy: New Insights into Its Surgical Implication.

Journal: Journal of minimally invasive gynecology
Published: January 10, 2024

Unraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1.

Unraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1.

Journal: Journal of ovarian research
Published: November 16, 2023

CD47-a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features.

CD47-a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features.

Journal: World journal of surgical oncology
Published: October 09, 2023

A randomized controlled trial to compare short-term outcomes following infragastric and infracolic omentectomy at the time of primary debulking surgery for epithelial ovarian cancer with normal-appearing omentum.

A randomized controlled trial to compare short-term outcomes following infragastric and infracolic omentectomy at the time of primary debulking surgery for epithelial ovarian cancer with normal-appearing omentum.

Journal: Journal of ovarian research
Published: June 18, 2023

Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer.

Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer.

Journal: World journal of surgical oncology
Published: June 10, 2023

68Ga-FAPI-04 PET/MR Versus 18F-FDG PET/CT in the Detection of Ovarian Cancer.

68Ga-FAPI-04 PET/MR Versus 18F-FDG PET/CT in the Detection of Ovarian Cancer.

Journal: Clinical nuclear medicine
Published: May 03, 2023

Tumor cell SPTBN1 inhibits M2 polarization of macrophages by suppressing CXCL1 expression.

Tumor cell SPTBN1 inhibits M2 polarization of macrophages by suppressing CXCL1 expression.

Journal: Journal of cellular physiology
Published: April 27, 2023
Showing 1-12 of 65

Last Updated: 09/26/2026